Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AbbVie
Company Monitoring Page for AbbVie
latest headlines for company on cafepharma
Abbvie Is One Of The Most 'Dislocated Names' In Pharma
Yahoo/Benzinga
Wed, 09/7/16 - 08:05 pm
Tags:
AbbVie
AbbVie: Not Your Father’s Biotech Company?
Barron's
Fri, 09/2/16 - 10:28 pm
Tags:
AbbVie
Why AbbVie Won't Pull A Galapagos On Ablynx
Seeking Alpha
Tue, 08/30/16 - 09:47 am
Tags:
AbbVie
,
Galapagos
,
Ablynx
,
vobarilizumab
How Late-Stage Asset Rova-T Could Become a Leading Therapy
Market Realist
Fri, 08/26/16 - 09:56 am
Tags:
Rova-T
,
AbbVie
,
small cell lung cancer
How AbbVie Expects Risankizumab to Be a Transformative Therapy
Market Realist
Wed, 08/24/16 - 10:40 am
Tags:
AbbVie
,
risankizumab
,
Crohn's Disease
Top 5 Drug Stocks of 2016
Investopedia
Sun, 08/21/16 - 12:19 pm
Tags:
AbbVie
,
JNJ
,
Celgene
,
Biogen
,
Bristol-Myers Squibb
AbbVie Inc Humira: What are the Future Prospects?
Bidness, ETC
Sat, 08/20/16 - 01:55 pm
Tags:
AbbVie
,
Humira
Will AbbVie bite? Decision time after Ablynx’s rheumatoid arthritis drug fails a key study
Endpoints
Tue, 08/9/16 - 10:46 pm
Tags:
Ablynx
,
AbbVie
,
rheumatoid arthritis
,
vobarilizumab
AbbVie Inc, Amgen, Inc: Lengthy Legal Battle Over Humira Begins
Bidness, ETC
Mon, 08/8/16 - 10:03 am
Tags:
AbbVie
,
Amgen
,
Humira
,
biosimilars
Elliott Associates sues AbbVie over failed bid for Shire
Yahoo/Reuters
Sat, 08/6/16 - 01:11 pm
Tags:
AbbVie
,
Shire
,
M&A
AbbVie Sues Amgen to Fend Off Copy of Blockbuster Humira
Yahoo/Bloomberg
Sat, 08/6/16 - 12:53 pm
Tags:
AbbVie
,
Amgen
,
Humira
,
generics
,
biosimilars
,
rheumatoid arthritis
AbbVie: What Will Happen After Humira?
Seeking Alpha
Thu, 08/4/16 - 09:07 pm
Tags:
AbbVie
,
Humira
AbbVie Inc: New Drugs May Overcome Humira Loss
Bidness, ETC
Mon, 08/1/16 - 03:56 pm
Tags:
AbbVie
,
Humira
,
Rova-T
,
Venclexta
,
Imbruvica
,
Viekira Pak
AbbVie profit and revenue beat expectations, raises 2016 guidance
Marketwatch
Fri, 07/29/16 - 11:35 am
Tags:
AbbVie
,
earnings
AbbVie Receives U.S. FDA Approval of Once-Daily VIEKIRA XR™ (dasabuvir, ombitasvir, paritaprevir and ritonavir) for the Treatment of Genotype 1 Chronic Hepatitis C
Yahoo
Wed, 07/27/16 - 09:48 am
Tags:
AbbVie
,
Viekira XR
AbbVie and Bristol-Myers Squibb to collaborate on lung cancer clinical trial
Marketwatch
Mon, 07/25/16 - 10:55 am
Tags:
AbbVie
,
Bristol-Myers Squibb
,
lung cancer
,
clinical trials
,
Rova-T
,
Opdivo
How Abbvie's Humira Undercuts The Drug Industry Price Defense
Forbes
Thu, 07/21/16 - 09:03 am
Tags:
AbbVie
,
Humira
,
drug pricing
FDA panel to review Humira, Enbrel biosimilars this week
BioPharma Dive
Tue, 07/12/16 - 09:22 am
Tags:
FDA
,
advisory panels
,
Humira
,
Enbrel
,
biosimilars
,
ABP-501
,
Amgen
,
AbbVie
,
GP2015
,
Novartis
Inside AbbVie’s Plans to Target Multiple Myeloma and Acute Myeloid Leukemia Segments with Venclexta
Market Realist
Mon, 07/11/16 - 10:50 am
Tags:
AbbVie
,
Multiple Myeloma
,
acute myeloid leukemia
,
Venclexta
AbbVie Receives U.S. FDA Rare Pediatric Disease Designation for Investigational ABT-414 for the Treatment of a Type of Pediatric Brain Tumor known as Diffuse Intrinsic Pontine Glioma (DIPG)
Yahoo
Mon, 07/11/16 - 09:17 am
Tags:
AbbVie
,
pediatric
,
brain tumors
,
Diffuse Intrinsic Pontine Glioma
,
ABT-414
Pages
« first
‹ previous
…
49
50
51
52
53
54
55
56
57
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.